围绝经期女性糖尿病发病相关危险因素的研究进展

doi:10.3969/j.issn.1003-9198.2024.04.019

摘要/Abstract

摘要： 围绝经期是中老年女性重要的生理阶段,当前关于围绝经期女性糖尿病患病风险增高与否的研究结论并不完全一致。性激素水平改变、生殖年限、肥胖、血管舒缩症状(vasomotor symptoms, VMS)等因素可影响糖尿病的患病风险。其中,潮热、盗汗等VMS是导致围绝经期女性糖尿病患病风险升高的独立危险因素。规范的饮食控制运动、激素替代治疗、心理支持可能降低围绝经期女性糖尿病的发生风险。

中图分类号:

R 587.1

张萱纯, 杨昱, 赵一璟, 刘超, 王昆. 围绝经期女性糖尿病发病相关危险因素的研究进展[J]. 实用老年医学, 2024, 38(4): 410-413.

[1] JAMESON J L. Harrison's Endocrinology[M]. 3rd ed. New York: McGraw-Hill Education, 2018:171.
[2] PARK S K, HARLOW S D, ZHENG H, et al. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes[J]. Diabet Med, 2017, 34(4):531-538.
[3] MUKA T, ASLLANAJ E, AVAZVERDI N, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study[J]. Diabetologia, 2017, 60(10):1951-1960.
[4] WANG Y, TANG R, LUO M, et al. Follicle stimulating hormone and estradiol trajectories from menopausal transition to late postmenopause in indigenous Chinese women[J]. Climacteric, 2021, 24(1):80-88.
[5] HERBER-GAST G C, MISHRA G D. Early severe vasomotor menopausal symptoms are associated with diabetes[J]. Menopause, 2014, 21(8):855-860.
[6] JEONG H G, PARK H. Metabolic disorders in menopause[J]. Metabolites, 2022, 12(10):954.
[7] REN Y, ZHANG M, LIU Y, et al. Association of menopause and type 2 diabetes mellitus[J]. Menopause, 2019, 26(3):325-330.
[8] MATTHEWS K A, CRAWFORD S L, CHAE C U, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?[J]. J Am Coll Cardiol, 2009, 54(25):2366-2373.
[9] JANSSEN I, POWELL L H, CRAWFORD S, et al. Menopause and the metabolic syndrome: the study of women's health across the nation[J]. Arch Intern Med, 2008, 168(14):1568-1575.
[10] SORIGUER F, MORCILLO S, HERNANDO V, et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study[J]. Menopause, 2009, 16(4):817-821.
[11] LIZNEVA D, RAHIMOVA A, KIM S M, et al. FSH beyond fertility[J]. Front Endocrinol (Lausanne), 2019, 19(10):136.
[12] 杨帆, 曾凡清, 戚燕妮. 女性围绝经期卵巢储备功能与血糖代谢功能相关性的研究[J]. 中国糖尿病杂志, 2021,29(09):688-691.
[13] CHUNG H F, DOBSON A J, HAYASHI K, et al. Ethnic differences in the association between age at natural menopause and risk of type 2 diabetes among postmenopausal women: a pooled analysis of individual data from 13 cohort studies[J]. Diabetes Care, 2023, 46(11):2024-2034.
[14] RUTH K S, DAY F R, TYRRELL J, et al. Using human genetics to understand the disease impacts of testosterone in men and women[J]. Nat Med, 2020, 26(2):252-258.
[15] ZHANG H, WANG W, ZHAO J, et al. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome[J]. Front Endocrinol (Lausanne), 2023, 9(13):1085656.
[16] HAMMES S R, LEVIN E R. Impact of estrogens in males and androgens in females[J]. J Clin Invest, 2019, 129(5):1818-1826.
[17] MAGAGNINI M C, CONDORELLI R A, CIMINO L, et al. Does the ketogenic diet improve the quality of ovarian function in obese women?[J]. Nutrients, 2022, 14(19):4147.
[18] YUAN S, WANG L, SUN J, et al. Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation[J]. Int J Epidemiol, 2022, 51(6):1931-1942.
[19] PERSKY V, ABASILIM C, TSINTSIFAS K, et al. Sex hormones and diabetes in 45- to 74-year-old men and postmenopausal women: the hispanic community health study[J]. J Clin Endocrinol Metab, 2023, 108(7):1709-1726.
[20] HE L, FAN B, LI C, et al. Association between body mass index and diabetes mellitus are mediated through endogenous serum sex hormones among menopause transition women: a longitudinal cohort study[J]. Int J Environ Res Public Health, 2023, 20(3):1831.
[21] FENG C, JIN Z, SUN L, et al. Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells[J]. Mol Biol Rep, 2019, 46(5):4953-4965.
[22] ANAGNOSTIS P, CHRISTOU K, ARTZOUCHALTZI A M, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis[J]. Eur J Endocrinol, 2019, 180(1):41-50.
[23] HONIGBERG M C, ZEKAVAT S M, ARAGAM K, et al. Association of premature natural and surgical menopause with incident cardiovascular disease[J]. Jama, 2019, 322(24):2411-2421.
[24] LEBLANC E S, KAPPHAHN K, HEDLIN H, et al. Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative[J]. Menopause, 2017, 24(1):64-72.
[25] RUTH K S, DAY F R, HUSSAIN J, et al. Genetic insights into biological mechanisms governing human ovarian ageing[J]. Nature, 2021, 596(7872):393-397.
[26] HEIANZA Y, ARASE Y, KODAMA S, et al. Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17)[J]. Diabetes Care, 2013, 36(12):4007-4014.
[27] MAIR K M, GAW R, MACLEAN M R. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension[J]. Pulm Circ, 2020, 10(3):2045894020952019.
[28] LI J, LUO M, TANG R, et al. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study[J]. Climacteric, 2020, 23(1):46-52.
[29] RYU K J, PARK H, PARK J S, et al. Vasomotor symptoms: more than temporary menopausal symptoms[J]. J Menopausal Med, 2020, 26(3):147-153.
[30] GRAY K E, KATON J G, LEBLANC E S, et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes?[J]. Menopause, 2018, 25(5):520-530.
[31] LI J, LIU B, TANG R, et al. Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women[J]. Climacteric, 2021, 24(2):151-156.
[32] TANG R, FAN Y, LUO M, et al. Generaland central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study[J]. Front Endocrinol (Lausanne), 2022, 26(13):814872.
[33] BERMINGHAM K M, LINENBERG I, HALL W L, et al. Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study[J]. EBioMedicine, 2022, 85:104303.
[34] YAHAYA T. Role of epigenetics in the pathogenesis and management of type 2 diabetes mellitus[J]. Translation: UTJMS, 2019, 6:20-28.
[35] YUMI NORONHA N, DA SILVA RODRIGUES G, HARUMI YONEHARA NOMA I, et al. 14-weeks combined exercise epigenetically modulated 118 genes of menopausal women with prediabetes[J]. Front Endocrinol (Lausanne), 2022, 15(13):895489.
[36] ARMENI E, PASCHOU S A, GOULIS D G, et al. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency[J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(6):101561.
[37] 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58(1):4-21.
[38] SAMAMI E, SHAHHOSSEINI Z, ELYASI F. The effects of psychological interventions on menopausal hot flashes: a systematic review[J]. Int J Reprod Biomed, 2022, 20(4):255-272.
[39] 潘卫英, 池莹. 心理疏导联合体育锻炼对围绝经期女性主要症状、生存质量及不良情绪的影响[J]. 中国妇幼保健, 2022, 37(11):2104-2107.

围绝经期女性糖尿病发病相关危险因素的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 13

Metrics

推荐阅读 10

[1]	王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069.
[4]	单竹子, 王雪菲, 巫海娣, 刘冬梅, 姜华, 唐伟, 莫永珍, 崔焱. 老年2型糖尿病病人体脂率与血糖波动的相关性研究[J]. 实用老年医学, 2024, 38(7): 693-696.
[5]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[6]	刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437.
[7]	杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437.
[8]	王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.
[9]	唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259.
[10]	洪兵, 徐晓文, 俞伟男, 徐伟, 胡文. 老年2型糖尿病患者围术期中甘精胰岛素的应用[J]. 实用老年医学, 2010, 24(2): 132-134.
[11]	朱建一, 吕志刚, 史恒川. 同型半胱氨酸对老年2型糖尿病患者大血管病变的影响[J]. 实用老年医学, 2010, 24(2): 135-137.
[12]	巫海娣, 卞茸文, 胡艳. 2型糖尿病患者精氨酸刺激试验安全性及血钾变化临床观察[J]. 实用老年医学, 2010, 24(2): 138-140.
[13]	胡兰萍, 顾萍, 王坚, 邵加庆, 杜宏, 王扬天, 卢斌, 彭丽. 免疫印迹法检测老年2型糖尿病患者血清胰岛自身抗体的临床价值[J]. 实用老年医学, 2010, 24(2): 156-158.